Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Makrygeorgou

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The British Journal of Dermatology|March 17, 2017
Secukinumab shows reassuring low immunogenicityA Makrygeorgou
The British Journal of Dermatology|March 5, 2015
8th Georg Rajka International Symposium on Atopic Dermatitis: meeting reportS M C George, A Makrygeorgou
Clinical and Experimental Dermatology|July 21, 2011
Buccal prochlorperazine causing perioral fixed drug eruptionG Wylie, A Makrygeorgou, A D Burden
Clinical and Experimental Dermatology|October 1, 2014
Psoralen ultraviolet A-induced melanonychiaG J Parkins, A D Burden, A Makrygeorgou
The British Journal of Dermatology|December 11, 2007
C-reactive protein in psoriasisA Sergeant, A Makrygeorgou, W C Chan, et al.
The British Journal of Dermatology|October 2, 2020
Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo TrialK S Thomas, J M Batchelor, P Akram, et al.
The British Journal of Dermatology|September 13, 2020
An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial)T H Sach, K S Thomas, J M Batchelor, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The British Journal of Dermatology|March 17, 2017
Secukinumab shows reassuring low immunogenicityA Makrygeorgou
The British Journal of Dermatology|March 5, 2015
8th Georg Rajka International Symposium on Atopic Dermatitis: meeting reportS M C George, A Makrygeorgou
Clinical and Experimental Dermatology|July 21, 2011
Buccal prochlorperazine causing perioral fixed drug eruptionG Wylie, A Makrygeorgou, A D Burden
Clinical and Experimental Dermatology|October 1, 2014
Psoralen ultraviolet A-induced melanonychiaG J Parkins, A D Burden, A Makrygeorgou
The British Journal of Dermatology|December 11, 2007
C-reactive protein in psoriasisA Sergeant, A Makrygeorgou, W C Chan, et al.
The British Journal of Dermatology|October 2, 2020
Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo TrialK S Thomas, J M Batchelor, P Akram, et al.
The British Journal of Dermatology|September 13, 2020
An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial)T H Sach, K S Thomas, J M Batchelor, et al.
Pageof 1